Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,852 | 311 | 99.5% |
| Education | $39.97 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,223 | 38 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,122 | 32 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $640.40 | 23 | $0 (2023) |
| GlaxoSmithKline, LLC. | $561.27 | 27 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $555.10 | 29 | $0 (2020) |
| Amarin Pharma Inc. | $551.07 | 9 | $0 (2019) |
| ABBVIE INC. | $449.63 | 11 | $0 (2022) |
| Allergan, Inc. | $360.01 | 11 | $0 (2020) |
| PFIZER INC. | $339.77 | 25 | $0 (2023) |
| Lilly USA, LLC | $320.84 | 21 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $181.68 | 8 | ABIOMED ($68.37) |
| 2023 | $772.68 | 34 | GlaxoSmithKline, LLC. ($247.73) |
| 2022 | $471.75 | 26 | ABBVIE INC. ($80.70) |
| 2021 | $309.53 | 20 | Lilly USA, LLC ($57.75) |
| 2020 | $442.93 | 24 | Boehringer Ingelheim Pharmaceuticals, Inc. ($127.92) |
| 2019 | $1,415 | 63 | Boehringer Ingelheim Pharmaceuticals, Inc. ($245.37) |
| 2018 | $1,636 | 62 | Amarin Pharma Inc. ($256.21) |
| 2017 | $2,662 | 79 | Novo Nordisk Inc ($711.66) |
All Payment Transactions
316 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $25.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $42.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $20.06 | General |
| Category: Medical Device | ||||||
| 07/11/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Heart Failure | ||||||
| 07/11/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Heart Failure | ||||||
| 05/17/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $23.54 | General |
| Category: Medical Device | ||||||
| 02/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Gastroenterology | ||||||
| 01/10/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Hematology | ||||||
| 12/21/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Heart Failure | ||||||
| 12/21/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Heart Failure | ||||||
| 12/15/2023 | Abbott Laboratories | AMPLATZER TALISMAN (Device) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Structural Heart | ||||||
| 12/06/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV, OFEV | Food and Beverage | In-kind items and services | $19.59 | General |
| 11/29/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Diabetes Care | ||||||
| 09/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2023 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $16.56 | General |
| Category: Medical Device | ||||||
| 08/17/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/09/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Inflammation | ||||||
| 07/26/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/26/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.20 | General |
| Category: RESPIRATORY | ||||||
| 07/19/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Hematology | ||||||
| 06/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 06/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.53 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 651 | 1,314 | $320,116 | $109,888 |
| 2022 | 10 | 718 | 1,229 | $294,470 | $101,601 |
| 2021 | 9 | 694 | 1,135 | $270,716 | $98,153 |
| 2020 | 7 | 643 | 1,053 | $137,293 | $71,271 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 146 | 363 | $117,975 | $38,826 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 148 | 499 | $112,275 | $36,197 | 32.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 131 | 131 | $44,933 | $19,364 | 43.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 18 | $13,068 | $4,473 | 34.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 47 | 47 | $11,797 | $4,313 | 36.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 64 | $8,896 | $3,315 | 37.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 108 | 108 | $5,940 | $2,340 | 39.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 65 | $4,225 | $836.68 | 19.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 19 | $1,007 | $224.64 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 325 | $105,625 | $32,208 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 135 | 355 | $79,875 | $27,966 | 35.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 129 | 129 | $44,247 | $18,988 | 42.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 99 | 99 | $24,849 | $9,249 | 37.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 81 | 139 | $19,321 | $6,376 | 33.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 14 | $10,164 | $3,762 | 37.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 67 | 67 | $3,685 | $1,420 | 38.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 30 | 75 | $4,149 | $924.54 | 22.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 11 | 11 | $1,760 | $496.49 | 28.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 15 | $795.00 | $210.49 | 26.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 134 | 333 | $108,225 | $37,627 | 34.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 104 | 291 | $65,475 | $22,126 | 33.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 120 | 120 | $41,160 | $18,851 | 45.8% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 105 | 105 | $26,355 | $8,933 | 33.9% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 17 | 19 | $10,412 | $3,657 | 35.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 38 | 62 | $8,618 | $2,983 | 34.6% |
About Dr. James Higgins, D.O
Dr. James Higgins, D.O is a Family Medicine healthcare provider based in East Islip, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083708697.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Higgins, D.O has received a total of $7,892 in payments from pharmaceutical and medical device companies, with $181.68 received in 2024. These payments were reported across 316 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($7,852).
As a Medicare-enrolled provider, Higgins has provided services to 2,706 Medicare beneficiaries, totaling 4,731 services with total Medicare billing of $380,914. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location East Islip, NY
- Active Since 10/03/2006
- Last Updated 08/18/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083708697
Products in Payments
- Vascepa (Drug) $551.07
- XARELTO (Drug) $509.72
- JARDIANCE (Drug) $489.07
- FARXIGA (Drug) $462.79
- TRELEGY ELLIPTA (Drug) $327.34
- SPIRIVA RESPIMAT (Drug) $300.22
- Synthroid (Drug) $260.36
- Victoza (Drug) $250.23
- XIFAXAN (Drug) $231.04
- Saxenda (Drug) $224.79
- JANUVIA (Drug) $175.66
- Xultophy 100/3.6 (Drug) $166.67
- iPro2 (Device) $150.95
- CHANTIX (Drug) $143.14
- Livalo (Drug) $136.37
- UBRELVY (Drug) $135.20
- Wegovy (Drug) $132.72
- INVOKANA (Drug) $124.66
- AVYCAZ (Drug) $124.34
- TOUJEO (Drug) $113.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in East Islip
Dr. Michael Ladinsky, D.o, D.O
Family Medicine — Payments: $37,176
Dr. Maria Vaccari, Do, DO
Family Medicine — Payments: $24,728
Dr. Salvatore Giantinoto, D.o, D.O
Family Medicine — Payments: $12,422
Dr. Nicole Darrow, D.o, D.O
Family Medicine — Payments: $10,921
Dr. Lawrence Northorn, D.o, D.O
Family Medicine — Payments: $8,588
Dr. Michael Torelli, M.d, M.D
Family Medicine — Payments: $6,473